found that the activation of AKT is an independent prognostic factor and significantly correlated with MYCN amplification and advanced stage in a study with 116 NB patients (12), suggesting that AKT may be an important potential target for NB treatment. The gene discussed is AKT1; the disease is neuroblastoma.